Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.22
-0.29 (-2.76%)
At close: Jul 24, 2026, 4:00 PM EDT
10.25
+0.03 (0.29%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.48 billion as of July 24, 2026. Its market cap has decreased by -26.69% in one year.
Market Cap
3.48B
Enterprise Value
3.82B
1-Year Change
-26.69%
Ranking
Category
Stock Price
$10.22
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.48B, an increase of 2,921.76%. That is a compound annual growth rate of 48.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.47B | 37.23% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 4.06B |
| Parabilis Medicines | 3.92B |
| Dyne Therapeutics | 3.84B |
| Arcus Biosciences | 3.77B |
| Denali Therapeutics | 3.75B |
| NewAmsterdam Pharma Company | 3.71B |
| Enliven Therapeutics | 3.69B |
| Alumis | 3.67B |